Nrf2 Induction Re-establishes a Proper Neuronal Differentiation Program in Friedreich’s Ataxia Neural Stem Cells
Frataxin deficiency is the pathogenic cause of Friedreich’s Ataxia, an autosomal recessive disease characterized by the increase of oxidative stress and production of free radicals in the cell. Although the onset of the pathology occurs in the second decade of life, cognitive differences and defects...
Main Authors: | Piergiorgio La Rosa, Marta Russo, Jessica D’Amico, Sara Petrillo, Katia Aquilano, Daniele Lettieri-Barbato, Riccardo Turchi, Enrico S. Bertini, Fiorella Piemonte |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-07-01
|
Series: | Frontiers in Cellular Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fncel.2019.00356/full |
Similar Items
-
Targeting NRF2 for the Treatment of Friedreich’s Ataxia: A Comparison among Drugs
by: Sara Petrillo, et al.
Published: (2019-10-01) -
The NRF2 Signaling Network Defines Clinical Biomarkers and Therapeutic Opportunity in Friedreich’s Ataxia
by: Piergiorgio La Rosa, et al.
Published: (2020-01-01) -
The Nrf2 induction prevents ferroptosis in Friedreich's Ataxia
by: Piergiorgio La Rosa, et al.
Published: (2021-01-01) -
Friedreichs ataxia in a diabetic patient
by: Inna Igorevna Klefortova, et al.
Published: (2010-06-01) -
Inducible and reversible phenotypes in a novel mouse model of Friedreich’s Ataxia
by: Vijayendran Chandran, et al.
Published: (2017-12-01)